Last updated 30 days ago

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

80 patients around the world

Available in Spain, United States, Brazil

Hoffmann-La Roche

1Research sites

80Patients around the world

This study is for people with

Idiopathic Nephrotic Syndrome

Requirements for the patient

To 25 Years

All Gender

Medical requirements

Sites

Fundação Faculdade Regional de Medicina de São José do Rio Preto

Recruiting

Av. Brg. Faria Lima, 5544 Sao Jose do Rio Preto - Estado de São Paulo 15090-000

StudyINShore

SponsorHoffmann-La Roche

Conditions

Requirements

To 25 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05627557